Cases & Deals

  • Home
  • Practices
  • Genomatica enters sponsored research agreement relating to biofuels, acquires technology from REGI

Share

Genomatica enters sponsored research agreement relating to biofuels, acquires technology from REGI

June 2019

Client(s) Genomatica, Inc.

Jones Day represented Genomatica, Inc. in entering a sponsored research agreement for the development of advanced biofuels and acted as special IP counsel to Genomatica in its simultaneous acquisition of the assets of the life sciences division of Renewable Energy Group, Inc. ("REGI"). The technology assets acquired from REGI are Genomatica's third technology platform and will be used by Genomatica to make long chain chemicals and continue biofuels research and development started by REGI before the acquisition.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.